Histone deacetylase inhibitors: gathering pace

Area of Science:

• Epigenetics
• Molecular Biology
• Cancer Biology

Background:

• Reversible histone acetylation is crucial for epigenetic gene regulation.
• Acetylation influences broader physiological processes like proliferation and protein folding.
• Non-histone regulatory proteins are also affected by acetylation.

Purpose of the Study:

• To review the role of histone acetylation in gene expression and physiological processes.
• To highlight the impact of acetylation on non-histone proteins.
• To discuss the therapeutic potential of histone deacetylase (HDAC) inhibitors in cancer treatment.

Main Methods:

• Literature review of recent studies on histone acetylation.
• Analysis of the role of acetylation in various cellular functions.
• Examination of the mechanism of action and clinical relevance of HDAC inhibitors.

Main Results:

• Histone acetylation is a key epigenetic regulatory mechanism.
• Acetylation impacts diverse physiological processes beyond gene expression.
• Inhibition of HDAC induces apoptosis in tumor cells.

Conclusions:

• HDAC inhibitors show promise as a new class of cancer therapeutics.
• Understanding acetylation's role offers insights into mechanism-based cancer treatments.
• Further clinical trials are investigating HDAC inhibitors for cancer therapy.